Table 1.

Clinical features of patients with CLL B cells expressing sIgG

PatientSexAge at diagnosisBinet stage at diagnosisPB lymphs at diagnosis, 109/LDisease progressionTreatment and timing (y)Survival to date (y)
1F64A(0)11YesAt progression (8.0)13
2F82A(0)8NoNone11
3M59B80NoAt diagnosis (0)5.5
4F78A(0)8NoNone8.5
5*M56B7YesNone2.1
6M45A18NoNone8
7*F74A(1)12NoNone4
8M48A(0)22.1YesAt progression (10)14
9F55A(0)28YesAt progression (3.5)15
10M77A (1)45.9NoNone2
11M84A(0)8.7NoNone7
12M46A (0)39NoNone8
13F74A(0)11NoNone1.5
14F82A(0)71NoNone3
  • * Patients with paraproteins.